Background: The aim of the present study was to investigate the effectiveness of intradiscal steroid injection in the treatment of discogenic low back pain (DLBP) with neuropathic pain (NeP). Methods: A total of 18 patients with DLBP were enrolled and divided into two groups based on having NeP and not. The patients' records included the following clinical parameters: duration and intensity of LBP, the Quebec Back Pain Disability Scale [QBPDS], the Daily Sleep Interference Scale [DSIS] and a Leeds Assessment of Neuropathic Symptoms and Signs [LANSS] pain scale. Results: In our study, 38.8% of the patients had DLBP with NeP, whereas 61.2% had mainly nociceptive pain. As we investigated the mean changes of the QBPDS scores and intensity of LBP in patients with a LANSS score ≥12, a statistically significant reduction was found at the second week and third month after the treatment compared to pre-injection values (p<0.05). The mean reduction in the intensity of DLBP, the QBPDS scores and the DSIS scores from baseline to second week and third month after the treatment was greater in group 2 than in group 1. Conclusions: Intradiscal steroid injections appear to be an effective and promising treatment for NeP component in DLBP.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.